ExCellThera Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $5.3M

  • Investors
  • 4

ExCellThera General Information

Description

Developer of a cell therapy platform designed to address blood cancers. The company utilizes genetically engineered hematopoietic stem cells that focus on delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, enabling patients with blood cancers to access a potentially transformative treatment that aims to improve survival outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 2950 Chemin de Polytechnique
  • Chemin de Polytechnique
  • Montreal, Quebec H3T 1J4
  • Canada
+1 (514)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 2950 Chemin de Polytechnique
  • Chemin de Polytechnique
  • Montreal, Quebec H3T 1J4
  • Canada
+1 (514)

ExCellThera Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ExCellThera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 11-Apr-2025 $5.3M Completed Pre-Clinical Trials
3. Accelerator/Incubator 01-Oct-2024 Completed Pre-Clinical Trials
2. Grant 05-Apr-2017 $14.9K Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Jan-2015 Completed Pre-Clinical Trials
To view ExCellThera’s complete valuation and funding history, request access »

ExCellThera Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ExCellThera Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Government of Quebec Government
University of Toronto University
Centre for Commercialization of Regenerative Medicine Corporation
University of Toronto Entrepreneurship Accelerator/Incubator
To view ExCellThera’s complete investors history, request access »

ExCellThera FAQs

  • When was ExCellThera founded?

    ExCellThera was founded in 2014.

  • Where is ExCellThera headquartered?

    ExCellThera is headquartered in Montreal, Canada.

  • What is the size of ExCellThera?

    ExCellThera has 18 total employees.

  • What industry is ExCellThera in?

    ExCellThera’s primary industry is Drug Discovery.

  • Is ExCellThera a private or public company?

    ExCellThera is a Private company.

  • What is ExCellThera’s current revenue?

    The current revenue for ExCellThera is .

  • Who are ExCellThera’s investors?

    Government of Quebec, University of Toronto, Centre for Commercialization of Regenerative Medicine, and University of Toronto Entrepreneurship have invested in ExCellThera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process